Can-Fite BioPharma Ltd. Comprehensive Income
Can-Fite BioPharma Ltd. (CANF) reported Comprehensive Income of -$7.88 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-14.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-04-14
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|
| 2024-12-31 | -$7.88M 20-F · filed 2025-04-14 | |
| 2023-12-31 | -$7.63M 20-F · filed 2025-04-14 | |
| 2022-12-31 | -$10.17M 20-F · filed 2025-04-14 | |
| 2021-06-30 | -$5.10M 6-K · filed 2021-08-26 | |
| 2020-06-30 | -$8.23M 6-K · filed 2021-08-26 | |
| 2019-12-31 | -$12.63M 6-K · filed 2020-06-01 | |
| 2019-06-30 | -$4.89M 6-K · filed 2020-08-27 | |
| 2018-12-31 | -$6.57M 6-K · filed 2020-06-01 | |
| 2017-12-31 | -$4.21M 6-K · filed 2020-06-01 |